TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Vaccines, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Vaccines technology and learn how to protect your intellectual property.

Get complete Patent Opposition Report for Vaccines

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Vaccines industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Vaccines industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Vaccines industry

EP3237004Predicting Outcome Of Treatment With An Anti- 4 7 Integrin AntibodyTAKEDA PHARMACEUTICALFeb 7, 2025POLPHARMA BIOLOGICS
EP3270966Combination Of Hdac Inhibitor And Anti-Pd-1 Antibody For Treatment Of CancerSYNDAX PHARMACEUTICALSJan 31, 2025MAIWALD
EP3515475Chimeric Antigen Receptor (Car) That Targets Chemokine Receptor Ccr4 And Its UseTHE USA REPRESENTED BY THE SECRETARYJan 30, 2025WEICKMANN & WEICKMANN PARTMBB
EP3215166Altering Gene Expression In Cart Cells And Uses ThereofTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJan 24, 2025STRAWMAN
EP3411476Enhanced Production Of ImmunoglobulinsTRIANNIJan 24, 2025REGENERON PHARMACEUTICALS
EP3785730Aluminium Compounds For Use In Therapeutics And VaccinesVALNEVA AUSTRIAJan 24, 2025STRAWMAN
EP3215166Altering Gene Expression In Cart Cells And Uses ThereofTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJan 23, 2025MAIWALD
EP3191120Use Of Il-17 Antagonists To Inhibit The Progression Of Structural Damage In Psoriatic Arthritis PatientsNOVARTISJan 10, 2025MAIWALD
EP3888674Treatment Of Cancer Using Anti-Cd19 Chimeric Antigen ReceptorTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJan 3, 2025J A KEMP
EP3226887Methods For Treating Myelodysplastic Syndromes And Sideroblastic AnemiasACCELERON PHARMADec 20, 2024WUESTHOFF & WUESTHOFF PATENTANWALTE UND RECHTSANWALT PARTG MBB

To stay ahead in the competitive Vaccines industry, companies are constantly innovating. Here are the top patents facing oppositions in the Vaccines industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP3177645Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLINDIS BIOTECH10
EP3616720Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentOSAKA UNIVERSITY10
EP3322731Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBB9
EP2766040May 15, 2019Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabFHOFFMANN LA ROCHE9
EP2780375Sep 11, 2019Binding Molecules For Bcma And Cd3BOEHRINGER INGELHEIM8
EP3515465Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALS7
EP3283059Jan 3, 2024Method For Producing Rna CompositionsCUREVAC REAL ESTATE7
EP2780374Aug 21, 2019Binding Molecules For Bcma And Cd3AMGEN RESEARCH MUNICH7
EP3338794Feb 26, 2020Toxicity Management For Anti-Tumor Activity Of CarsTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA7
EP3498734Sep 1, 2021Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating CancerMERCK SHARP & DOHME7